The Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel).

BCVA 1 week after macula-off rhegmatogenous retinal detachment surgery most effectively predicts patients’ long-term visual outcomes.

A novel stem cell therapy demonstrated potential in restoring the corneal surface in patients with blinding corneal injuries.

HealthDay News — Obstructive sleep apnea (OSA) is associated with an increased risk for Parkinson disease (PD), according to a study scheduled for presentation at the annual meeting of the American ...

Researchers evaluated the outcomes of slow-coagulation transscleral cyclophotocoagulation combined with cataract surgery.

Investigators assessed glaucoma surgical outcomes and the need for surgical reoperation based on preoperative glaucoma ...

Researchers reviewed the use of melatonin as a sleep aid for patients with sleep disruptions due to primary open-angle ...

Patients who undergo surgery immediately preceding the weekend have an increased risk for complications, readmission, and mortality at 30 days, 90 days, and one year compared with those undergoing ...

Researchers used the National Institutes of Health All of Us to investigate peoples of non-European heritage for primary open ...

A measles outbreak in Texas has grown to 159 cases, and now the US Centers for Disease Control and Prevention (CDC) has sent a team to help local health officials respond.

Researchers investigated the long-term outcomes of ab-interno canaloplasty as a standalone procedure or in combination with ...

Researchers reviewed the 3-year clinical outcomes of patients who underwent cyclophotocoagulation following a failed glaucoma ...